Apogee Therapeutics, Inc. Common Stock (APGE) — Financial Flexibility Index
Apogee Therapeutics, Inc. Common Stock (APGE) has a Financial Flexibility Index of -1.88x as of December 2025. Free cash flow of $-62.63 Million (operating CF $-62.69 Million minus capex $62.00K) represents -2% of total liabilities ($33.25 Million). Also explore net asset growth rate of Apogee Therapeutics, Inc. Common Stock to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Apogee Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Apogee Therapeutics, Inc. Common Stock across 4 annual periods. Check APGE capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Apogee Therapeutics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for Apogee Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see APGE market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.69x | $-222.30 Million | $-227.45 Million | $33.25 Million | ▼ -46.1% |
| 2024 | -4.58x | $-170.02 Million | $-171.17 Million | $37.16 Million | ▼ -31.8% |
| 2023 | -3.47x | $-74.59 Million | $-74.76 Million | $21.49 Million | ▼ -110.9% |
| 2022 | -1.65x | $-16.43 Million | $-16.43 Million | $9.98 Million | — |